We are live on !
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$566M
Turnover
17.35%
1-Year Est. Return
197.74%
This Fund
S&P 500
This Quarter Est. Return
+96.59%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$566M
AUM Growth
+$191M
(+51%)
Cap. Flow
-$25.1M
Cap. Flow % of AUM
Cap. Flow %
-4.43%
Top 10 Holdings %
Top 10 Hldgs %
65.92%
Holding
98
New
12
Increased
27
Reduced
22
Closed
5
Avg Time Held
Equity + Options
2.4
years
Top 10 Avg Time Held
Equity + Options
2
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.33M |
| 2 |
HELP
Helus Pharma Inc. Common Stock
HELP
|
+$3.72M |
| 3 |
Microsoft
MSFT
|
+$3.33M |
| 4 |
Immuneering
IMRX
|
+$3.28M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$37.5M |
| 2 |
Eli Lilly
LLY
|
+$5.72M |
| 3 |
Cisco
CSCO
|
+$1.57M |
| 4 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$1.52M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.15% |
| 2 | Technology | 31.31% |
| 3 | Healthcare | 17.63% |
| 4 | Communication Services | 4.62% |
| 5 | Consumer Discretionary | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
Invesco QQQ Trust
QQQ
$488B
| $142M | 25.13% |
193,100
+67,100
| +53% | +$46.2M |
2025 Q4
2 quarters
|
|
|
2
Micron Technology
MU
$1.11T
| $115M | 20.4% |
100,000
-50,000
| -33% | -$37.5M |
2019 Q4
26 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$3.92T
| $19.1M | 3.37% |
54,000
-3,000
| -5% | -$1.07M |
2019 Q4
26 quarters
|
|
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $18.7M | 3.3% |
25,000
+3,500
| +16% | +$2.54M |
2025 Q4
2 quarters
|
|
5
Advanced Micro Devices
AMD
$938B
| $16.8M | 2.98% |
29,000
| – | – |
2019 Q4
26 quarters
|
|
|
6
CALL
Micron Technology
MU
$1.11T
| $14.4M | 2.55% |
+12,500
| New | +$9.37M |
2026 Q2
0 quarters
|
|
|
7
Amazon
AMZN
$2.74T
| $14.1M | 2.5% |
59,250
+21,250
| +56% | +$5.33M |
2024 Q2
8 quarters
|
|
8
argenx
ARGX
$56B
| $13.2M | 2.33% |
14,200
-450
| -3% | -$371K |
2019 Q4
26 quarters
|
|
9
Corvus Pharmaceuticals
CRVS
$876M
| $9.5M | 1.68% |
637,500
| – | – |
2025 Q4
2 quarters
|
|
|
HELP
10
Helus Pharma Inc. Common Stock
HELP
$791M
| $9.49M | 1.68% |
1,434,988
+743,000
| +107% | +$3.72M |
2025 Q4
2 quarters
|
|
|
11
Teva Pharmaceutical Industries Limited
TEVA
$46.7B
| $8.62M | 1.52% |
254,500
-45,500
| -15% | -$1.52M |
2023 Q2
12 quarters
|
|
12
Marvell Technology
MRVL
$224B
| $8.19M | 1.45% |
27,500
| – | – |
2021 Q1
21 quarters
|
|
13
iShares Gold Trust
IAU
$60.2B
| $7.55M | 1.33% |
100,000
| – | – |
2019 Q4
26 quarters
|
|
14
Bank of America
BAC
$352B
| $6.81M | 1.2% |
119,500
| – | – |
2019 Q4
26 quarters
|
|
15
Regeneron Pharmaceuticals
REGN
$83.7B
| $5.77M | 1.02% |
9,250
| – | – |
2019 Q4
26 quarters
|
|
16
Energy Transfer Partners
ET
$71.3B
| $5.75M | 1.02% |
300,500
| – | – |
2025 Q4
2 quarters
|
|
|
17
Vertex Pharmaceuticals
VRTX
$134B
| $5.71M | 1.01% |
11,500
+4,500
| +64% | +$1.99M |
2025 Q4
2 quarters
|
|
18
SPDR Gold Trust
GLD
$136B
| $5.16M | 0.91% |
14,000
+2,000
| +17% | +$829K |
2019 Q4
26 quarters
|
|
19
Citigroup
C
$206B
| $5.04M | 0.89% |
36,000
| – | – |
2023 Q2
12 quarters
|
|
20
NewAmsterdam Pharma
NAMS
$2.48B
| $4.78M | 0.84% |
141,000
-19,600
| -12% | -$646K |
2024 Q3
7 quarters
|
|
21
VanEck Gold Miners ETF
GDX
$25.5B
| $4.72M | 0.83% |
62,500
| – | – |
2023 Q2
12 quarters
|
|
22
Incyte
INCY
$23.7B
| $4.7M | 0.83% |
41,500
| – | – |
2019 Q4
26 quarters
|
|
|
23
Cisco
CSCO
$435B
| $4.7M | 0.83% |
40,000
-15,000
| -27% | -$1.57M |
2022 Q1
17 quarters
|
|
24
Baidu
BIDU
$26.9B
| $4.57M | 0.81% |
40,000
-1,000
| -2% | -$124K |
2024 Q1
9 quarters
|
|
25
Oracle
ORCL
$443B
| $4.47M | 0.79% |
30,500
+2,000
| +7% | +$362K |
2019 Q4
26 quarters
|
|
Similar funds
LT
DCF Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, DCF Advisers held 98 positions worth $566M, up 51% from $375M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
DCF Advisers withdrew a net $25.1M in Q2 2026, closing 5 positions and reducing 22 holdings. Its most notable exit was Synopsys, an estimated $496K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DCF Advisers opened a new position in MarineMax worth $2.11M.
- DCF Advisers's largest Q2 2026 buy was MarineMax: 57,500 shares worth $2.11M.
- DCF Advisers added most to Amazon in Q2 2026, an estimated $5.33M increase.
- DCF Advisers's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $37.5M.
- DCF Advisers fully exited Synopsys in Q2 2026, selling an estimated $496K.
- DCF Advisers's ten largest holdings make up 66% of its $566M portfolio in Q2 2026.
- DCF Advisers opened 12 new positions and closed 5 in Q2 2026.
- DCF Advisers's portfolio value rose 51% quarter-over-quarter to $566M.
Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.